PHS
AVXS

PFM Health Sciences’s AveXis, Inc. Common Stock AVXS Stock Holding History

PFM Health Sciences’s Portfolio AVXS Stock Details AVXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-70,170
Closed -$5.33M – 125
2017
Q1 		$5.33M Buy
+70,170
New +$4.34M 0.13% 91

Other funds holding AVXS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PFM Health Sciences's AVXS Position: Q2 2017 in Review

PFM Health Sciences sold out of AveXis, Inc. Common Stock (AVXS) in Q2 2017, closing a stake of 70,170 shares — an estimated $5.33M sold.

PFM Health Sciences first reported a position in AVXS in Q1 2017 and held it in 1 quarter. The position peaked at $5.33M in Q1 2017. 116 funds tracked by Wall St. Rank hold AVXS as of Q2 2017.

  • PFM Health Sciences reported no remaining AveXis, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • PFM Health Sciences sold 70,170 AveXis, Inc. Common Stock shares in Q2 2017, an estimated $5.33M.
  • PFM Health Sciences first reported a position in AveXis, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • PFM Health Sciences's AveXis, Inc. Common Stock position peaked at $5.33M in Q1 2017.
  • 116 funds tracked by Wall St. Rank held AveXis, Inc. Common Stock as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.